Catholic Health Initiatives:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Catholic Health Initiatives - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12382
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Catholic Health Initiatives (CHI) is a health system comprising of non-profit and for profit corporations and other organizations including Catholic health care systems. It serves people through operations and facilities that span the continuum of care, comprising acute care hospitals; long-term care facilities; physician practices; assisted-living and residential-living facilities; home care; community-based health services; medical and nursing education; reference laboratory services; research and development; virtual health services; managed care programs; and insurance products. The organization’s operations are principally located in Arkansas, Colorado, Iowa, Kentucky, Nebraska, Ohio, Pacific Northwest, Tennessee, Texas and North Dakota/Minnesota. CHI is headquartered in Englewood, Colorado, the US.

Catholic Health Initiatives – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Catholic Health Initiatives, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Catholic Health Initiatives, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Catholic Health Initiatives, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Catholic Health Initiatives, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Catholic Health Initiatives, Medical Devices Deals, 2012 to YTD 2018 9
Catholic Health Initiatives, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Catholic Health Initiatives, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Catholic Health Initiatives And St. Vincent Health System Completes Acquisition Of Mercy Hot Springs From Mercy Health 11
Venture Financing 12
Carena Raises USD13.3 Million in Venture Financing 12
Carena Raises US$14 Million In Venture Financing 13
Partnerships 14
Seven Hospitals and Three Philanthropic Foundations Form Civica RX 14
Debt Offering 16
Catholic Health Initiatives Completes Public Offering Of Series 2013 Term Bonds Due 2045 For US$198.4 Million 16
Catholic Health Initiatives Completes Public Offering Of Series 2013 Term Bonds Due 2040 For US$46.6 Million 17
Catholic Health Initiatives Completes Public Offering Of Series 2013 Term Bonds Due 2033 For US$9.7 Million 18
Asset Transactions 19
Acadia Healthcare Acquires Inpatient Psychiatric Facility From Highline Medical Center For US$20 Million 19
Avera Health Completes Acquisition Of St. Mary’s Healthcare Center From Catholic Health Initiatives 20
Acquisition 21
Penn State Health Acquires St. Joseph Regional Health Network from Catholic Health Initiatives 21
Catholic Health Completes Acquisition Of St. Luke’s Episcopal Health System 22
University of Maryland Medical Completes Acquisition Of St. Joseph Medical Center From Catholic Health Initiatives 23
Catholic Health Initiatives Completes Acquisition Of 50% Stake In Alegent Creighton 24
Catholic Health Initiatives – Key Competitors 25
Catholic Health Initiatives – Key Employees 26
Catholic Health Initiatives – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Joint Venture 29
Recent Developments 30
Strategy And Business Planning 30
Sep 06, 2018: Catholic Health initiatives joins six other Health Systems to form National Nonprofit Generic Drug Company 30
Sep 06, 2018: Not-for-profit generic drug company officially established, attracts interest of more than 120 health organizations 31
Government and Public Interest 32
Sep 06, 2018: Three National Foundations Commit $30 Million to Civica Rx, a Groundbreaking Effort to Address Shortages and High Prices of Life-Saving Medications 32
Aug 10, 2017: Catholic Health Initiatives Receives $2.5 million Grant from the Robert Wood Johnson Foundation to Create New Model for Healthier Populations 33
Other Significant Developments 35
Nov 15, 2018: CommonSpirit Health chosen as name for new system 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Catholic Health Initiatives, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Catholic Health Initiatives, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Catholic Health Initiatives, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Catholic Health Initiatives, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Catholic Health Initiatives, Deals By Therapy Area, 2012 to YTD 2018 9
Catholic Health Initiatives, Medical Devices Deals, 2012 to YTD 2018 10
Catholic Health Initiatives, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Catholic Health Initiatives And St. Vincent Health System Completes Acquisition Of Mercy Hot Springs From Mercy Health 12
Carena Raises USD13.3 Million in Venture Financing 13
Carena Raises US$14 Million In Venture Financing 14
Seven Hospitals and Three Philanthropic Foundations Form Civica RX 15
Catholic Health Initiatives Completes Public Offering Of Series 2013 Term Bonds Due 2045 For US$198.4 Million 17
Catholic Health Initiatives Completes Public Offering Of Series 2013 Term Bonds Due 2040 For US$46.6 Million 18
Catholic Health Initiatives Completes Public Offering Of Series 2013 Term Bonds Due 2033 For US$9.7 Million 19
Acadia Healthcare Acquires Inpatient Psychiatric Facility From Highline Medical Center For US$20 Million 20
Avera Health Completes Acquisition Of St. Mary’s Healthcare Center From Catholic Health Initiatives 21
Penn State Health Acquires St. Joseph Regional Health Network from Catholic Health Initiatives 22
Catholic Health Completes Acquisition Of St. Luke’s Episcopal Health System 23
University of Maryland Medical Completes Acquisition Of St. Joseph Medical Center From Catholic Health Initiatives 24
Catholic Health Initiatives Completes Acquisition Of 50% Stake In Alegent Creighton 25
Catholic Health Initiatives, Key Competitors 26
Catholic Health Initiatives, Key Employees 27
Catholic Health Initiatives, Subsidiaries 29
Catholic Health Initiatives, Joint Venture 30

List of Figures
Catholic Health Initiatives, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Catholic Health Initiatives, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Catholic Health Initiatives, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Catholic Health Initiatives, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Catholic Health Initiatives, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Catholic Health Initiatives, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Catholic Health Initiatives, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Catholic Health Initiatives, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Catholic Health Initiatives, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Catholic Health Initiatives:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Samsung Electronics Co Ltd (005930)-医療機器分野:企業M&A・提携分析
    Summary Samsung Electronics Co., Ltd. (Samsung) is a manufacturer of consumer electronics, information technology and mobile communications, and device solutions. The company’s product portfolio includes television (TV), washing machine, refrigerator, air conditioner, medical devices, monitor, print …
  • MediPal Holdings Corp:企業の戦略・SWOT・財務情報
    MediPal Holdings Corp - Strategy, SWOT and Corporate Finance Report Summary MediPal Holdings Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Protea Biosciences Group Inc (PRGB)-医療機器分野:企業M&A・提携分析
    Summary Protea Biosciences Group Inc (Protea) is a biotechnology company that develops mass spectometry solutions. The company offers technology for the characterization, identification, and quantitation of biologically-important molecules for research, pharmaceutical development, and diagnostic app …
  • Marquette Capital Partners LLC:企業の戦略・SWOT・財務情報
    Marquette Capital Partners LLC - Strategy, SWOT and Corporate Finance Report Summary Marquette Capital Partners LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Inflection Biosciences Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Inflection Biosciences Ltd (Inflection Biosciences) is a drug development company focused on discovery and development of small molecule therapeutics for the treatment of cancer. The company’s pipeline products include dual mechanism kinase inhibitors and pim kinase inhibitors including IBL- …
  • EllisDon Corporation:企業の戦略・SWOT・財務分析
    EllisDon Corporation - Strategy, SWOT and Corporate Finance Report Summary EllisDon Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • BioTime Inc (BTX):製薬・医療:M&Aディール及び事業提携情報
    Summary BioTime Inc (BioTime) is a biotechnology company which focuses on regenerative medicine and plasma volume expanders. The company’s Hextend is a blood plasma volume expander used for the treatment of hypovolemia in surgery, emergency trauma treatment, and other applications. It is also develo …
  • The Bank of Nagoya, Ltd.:企業の戦略・SWOT・財務情報
    The Bank of Nagoya, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Bank of Nagoya, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Brown & Brown, Inc.:企業の戦略・SWOT・財務情報
    Brown & Brown, Inc. - Strategy, SWOT and Corporate Finance Report Summary Brown & Brown, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • ZTE Corp:企業の戦略・SWOT・財務情報
    ZTE Corp - Strategy, SWOT and Corporate Finance Report Summary ZTE Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Stratasys Ltd:企業の戦略・SWOT・財務情報
    Stratasys Ltd - Strategy, SWOT and Corporate Finance Report Summary Stratasys Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Aldevron LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Aldevron LLC (Aldevron) is a provider of contract plasmid DNA manufacturing, protein production and antibody discovery services. The company develops and manufactures plasmid deoxyribonucleic acid (Plasmid DNA), proteins and antibodies for research, preclinical and clinical applications serv …
  • Atlantic Pro-Nutrients Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Atlantic Pro-Nutrients Inc (APN) is a health science company that manufactures dietary supplements and functional foods. The company offers products in the areas of women's health, men's health, sports nutrition, immune health, cytokine balance support, adrenal support, antioxidants, bone he …
  • Abercrombie & Fitch Co.:企業の戦略・SWOT・財務情報
    Abercrombie & Fitch Co. - Strategy, SWOT and Corporate Finance Report Summary Abercrombie & Fitch Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Corcept Therapeutics Inc (CORT):企業の財務・戦略的SWOT分析
    Corcept Therapeutics Inc (CORT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • SK Telecom Co., Ltd.:戦略・SWOT・企業財務分析
    SK Telecom Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary SK Telecom Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Global Ports Holding PLC (GPH):企業の財務・戦略的SWOT分析
    Global Ports Holding PLC (GPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Nuance Communications Inc (NUAN):医療機器:M&Aディール及び事業提携情報
    Summary Nuance Communications Inc (Nuance) is a provider of speech and imaging solutions. The company, offers solutions such as optical character recognition (OCR), automated speech recognition, capabilities for natural language understanding, domain knowledge and implementation capabilities, dialog …
  • Farmer Bros. Co. (FARM):企業の財務・戦略的SWOT分析
    Farmer Bros. Co. (FARM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Barton Malow Co:企業の戦略的SWOT分析
    Barton Malow Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆